Although the A allele of IGFBP-3 rs2854744 is positively associated with circulating IGFBP-3 levels, with a distinct dose-response relationship [33–35], there remains conflicting evidence about the association between IGFBP-3 rs2854744 and BC risk. This evidence concerns the gene IGFBP3 and breast cancer.